3

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: June 26, 2015
Period of Report: June 15, 2015
Accession Number: 0001645627-15-000001

View Document ↗ View on SEC.gov ↗